Anthera Pharmaceuticals Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Public

  • Employees
  • 21

Employees

  • Stock Symbol
  • ANTH

Stock Symbol

  • Investments
  • 1

Anthera Pharmaceuticals General Information

Description

Anthera Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. The company currently has one Phase 3-ready clinical program and two Phase 2 clinical programs. It was established in 2004.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 700 Milam
  • Suite 1300
  • Houston, TX 77002
  • United States
+1 (410)
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
OTCM
Corporate Office
  • 700 Milam
  • Suite 1300
  • Houston, TX 77002
  • United States
+1 (410)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anthera Pharmaceuticals Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
11.2K

Anthera Pharmaceuticals Financials Summary

As of 31-Mar-2018, Anthera Pharmaceuticals has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 31-Mar-2018 FY 2017 31-Dec-2017 FY 2016 31-Dec-2016 FY 2015 31-Dec-2015
EV 5,610 17,109 (1,648) 129,260
Revenue 0 0 145 3,185
EBITDA (22,994) (26,593) (55,257) (34,935)
Net Income (23,391) (26,874) (55,523) (35,220)
Total Assets 8,811 3,673 23,471 48,125
Total Debt 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Anthera Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Anthera Pharmaceuticals‘s full profile, request access.

Request a free trial

Anthera Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Anthera Pharmaceuticals‘s full profile, request access.

Request a free trial

Anthera Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Anthera Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing products to tr
Pharmaceuticals
Houston, TX
21 As of 2017

Long Beach, CA
 

Pasadena, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Anthera Pharmaceuticals Competitors (94)

One of Anthera Pharmaceuticals’s 94 competitors is Dermavant Sciences, a Formerly PE-Backed company based in Long Beach, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Dermavant Sciences Formerly PE-Backed Long Beach, CA
Arrowhead Pharmaceuticals Corporation Pasadena, CA
Alaunos Therapeutics Formerly VC-backed Fort Lauderdale, FL
Moderna Formerly VC-backed Cambridge, MA
Incyte Formerly VC-backed Wilmington, DE
You’re viewing 5 of 94 competitors. Get the full list »

Anthera Pharmaceuticals Patents

Anthera Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170369551-A1 Methods of treating iga nephropathy and henoch-schonlein purpura nephritis using a b-cell activating factor (baff) inhibitor Inactive 24-Jun-2016
WO-2017223534-A2 Methods of treating iga nephropathy and henoch-schönlein purpura nephritis using a b-cell activating factor (baff) inhibitor Inactive 24-Jun-2016
WO-2017223534-A3 Methods of treating iga nephropathy and henoch-schönlein purpura nephritis using a b-cell activating factor (baff) inhibitor Inactive 24-Jun-2016
US-20110301202-A1 Spla2 inhibitor conjugate compounds and methods of use Inactive 04-Jun-2010
WO-2011153433-A1 Spla2 inhibitor conjugate compounds and methods of use Inactive 04-Jun-2010 A61K31/4439
To view Anthera Pharmaceuticals’s complete patent history, request access »

Anthera Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Anthera Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Anthera Pharmaceuticals‘s full profile, request access.

Request a free trial

Anthera Pharmaceuticals Investments (1)

Anthera Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with Eli Lilly and Company (Sollpura). The deal was made on 14-Jul-2014.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Eli Lilly and Company (Sollpura) 14-Jul-2014 Corporate Asset Purchase Buildings and Property
To view Anthera Pharmaceuticals’s complete investments history, request access »

Anthera Pharmaceuticals FAQs

  • When was Anthera Pharmaceuticals founded?

    Anthera Pharmaceuticals was founded in 2004.

  • Where is Anthera Pharmaceuticals headquartered?

    Anthera Pharmaceuticals is headquartered in Houston, TX.

  • What is the size of Anthera Pharmaceuticals?

    Anthera Pharmaceuticals has 21 total employees.

  • What industry is Anthera Pharmaceuticals in?

    Anthera Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Anthera Pharmaceuticals a private or public company?

    Anthera Pharmaceuticals is a Public company.

  • What is Anthera Pharmaceuticals’s stock symbol?

    The ticker symbol for Anthera Pharmaceuticals is ANTH.

  • Who are Anthera Pharmaceuticals’s competitors?

    Dermavant Sciences, Arrowhead Pharmaceuticals, Alaunos Therapeutics, Moderna, and Incyte are some of the 94 competitors of Anthera Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process